Deutsche Bank sees more than a 30% rally for this specialty biotech stock
Deutsche Bank is more bullish on Catalent after the New Jersey-based company expanded its manufacturing partnership with Moderna . Catalent shares were upgraded to buy from hold on Monday, with…